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Background
Cardiac Magnetic Resonance (CMR) provides superior
assessment of right ventricle (RV) function and assess-
ment of multiple physiologic parameters with high
inter- and intraobserver reproducibility thus providing a
noninvasive assessment of pulmonary arterial hyperten-
sion (PAH) by evaluating RV physiologic parameters.
CMR also provides a unique noninvasive assessment of
myocardial fibrosis and quantitative evaluation of RV
mass. Our goal was to evaluate the value of CMR to
assess RV dysfunction in the setting of PAH using
established physiologic parameter in combination with
techniques unique to CMR, such as RV mass quantifica-
tion and T1-mapping.
Methods
18 patients with PAH (13F, 8M, 40-79 yrs) confirmed by
right-heart catheterization underwent CMR (Siemens
Aera, 1.5T) with multi-planar steady state free precession
(SSFP) sequences. T1-mapping pre- and post-contrast
using a modified Look-Locker inversion recovery
(MOLLI) sequence and the shortened (ShMOLLI) ver-
sion were also performed. 13 controls (5F, 8M, 18-76 yrs)
were patients referred for CMR to evaluate for ARVD or
an echocardiogram abnormality and were normal on
CMR. Post-processing software was performed to deter-
mine biventricular ejection fractions (EF) and myocardial
mass. Pulmonary and tricuspid annular plane systolic
excursion (PAPSE & TAPSE) and MPA size were mea-
sured in RVOT, 4-chamber, and LVOT views respec-
tively. Left ventricle eccentricity index in end diastole
(LVEId) and end systole (LVEIs) were performed in the
in a mid short-axis slice. Parametric T1 values were iden-
tified by ROI placement on the interventricular septum
and LV blood pool before and after contrast to generate
a partition coefficient. A logistic regression comparing
PAH patients to controls as the dependent variable was
performed. RVEF, RV mass, PAPSE, TAPSE, LVEId,
LVEIS, and MPA size were used as independent vari-
ables. For T1-mapping, the T1 septal values before and
after contrast, and partition coefficients were evaluated as
independent variables.
Results
RVEF, RV mass, PAPSE, and MPA size were significant
predictors of PAH. RVEF (mean 34.86 ± 12.11, p =
0.043) and MPA size (mean 3.31 ± 0.55, p = 0.006) are
well established PAH predictors. PAPSE in PAH
patients (mean 8.98 ± 4.56, p = 0.026) was lower com-
pared to controls (mean 13.20 ± 2.74), and met statisti-
cal significance compared to TAPSE (p=0.319).
Increased RV mass (mean 39.86 ± 13.01, p = 0.010) in
PAH patients was found compared to controls (mean
23.70 ± 6.20). T1-mapping showed that only pre-con-
trast ShMOLLI T1 signal measurements correlated with
PAH (p=0.007). Multiple regression confirmed that the
most significant imaging findings were MPA size, RV
mass, and PAPSE respectively.
Conclusions
CMR offers unique quantitative assessment of RV mass
and PAPSE, which are significant predictors of PAH.
Given current use of CMR for RVEF calculation for
PAH prognosis, CMR with the addition of RV mass and
PAPSE should be considered for first-line noninvasive
PAH diagnosis.
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